Diclofenac Sodium Topical Gel to Reduce Injection Site Discomfort in Patients Taking Glatiramer Acetate

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2011
The purpose of this study is to assess the effect of Diclofenac Sodium Topical Gel (DSTG) on injection site reaction following self-administer glatiramer acetate in people with Multiple Sclerosis.
Epistemonikos ID: bec20dee6c71437b4311a2fb426cdd0fa5b0dcbb
First added on: Mar 31, 2022